SELLAS Life Sciences Group, Inc. (SLS): Capital Expenditures
Older than the company's other figures. The latest Capital Expenditures is for the year ended 2016-12-31, while the company's latest annual report covers the year ended 2025-12-31. Its later filings do not report this line under the concept TickerFacts maps.
$6.0K
Year ended 2016-12-31
-73.4%
3-year compound annual growth
-35.3%
5-year compound annual growth
| Period ended | Capital Expenditures | Change YoY | Source filing |
|---|---|---|---|
| 2016-12-31 | $6.0K | -96.1% | 2017-03-15, From 2016-01-01 |
| 2015-12-31 | $153.0K | +168.4% | 2017-03-15, From 2015-01-01 |
| 2014-12-31 | $57.0K | -82.2% | 2017-03-15, From 2014-01-01 |
| 2013-12-31 | $320.0K | n/a | 2016-04-15, From 2013-01-01 |
| No annual figure between 2011-12-31 and 2013-12-31. | |||
| 2011-12-31 | $53.0K | -50.0% | 2014-03-17, From 2011-01-01 |
| 2010-12-31 | $106.0K | n/a | 2012-03-28, From 2010-01-01 |